TFF PHARMACEUTICALS I

TFF Pharmaceuticals Announces It Will Wind Down Operations

14 نوفمبر 2024 15:15:00 بحسب Nasdaq GlobeNewswire

TFF Pharmaceuticals’ Technology Generates Superior Inhalational Dry Powder Formulations for Pulmonary Drug Delivery

26 سبتمبر 2024 06:00:00 بحسب Nasdaq GlobeNewswire

TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID

11 سبتمبر 2024 06:00:00 بحسب Nasdaq GlobeNewswire

TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization

10 سبتمبر 2024 06:00:00 بحسب Nasdaq GlobeNewswire

TFF Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

03 سبتمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire